The Steno-2 Study has previously demonstrated marked risk reductions in cardiovascular disease with intensified polypharmacological treatment of patients with type 2 diabetes and microalbuminuria after 8 years of intensified multifactorial intervention. The present long-term follow-up demonstrates an absolute 20% risk reduction in total and 13% in cardiovascular mortality. Risk reductions for cardiovascular disease were even more pronounced after 13 years of follow-up than after 8 years. The earlier intensive treatment was initiated, the more patients seemed to benefit.
|Bidragets oversatte titel||Intensive multifactorial treatment and mortality of patients with type 2 diabetes|
|Tidsskrift||Ugeskrift for laeger|
|Status||Udgivet - 10 mar. 2008|